LivaNova PLC, a prominent player in the medical technology sector, is headquartered in the United Kingdom. Founded in 2015 through the merger of Sorin Group and Cyberonics, LivaNova has established itself as a leader in cardiac and neuromodulation therapies. The company operates extensively across Europe, North America, and Asia, focusing on innovative solutions that enhance patient care. LivaNova's core offerings include advanced cardiac devices, such as heart valves and perfusion systems, alongside neuromodulation products for epilepsy and depression. What sets LivaNova apart is its commitment to research and development, driving breakthroughs that improve surgical outcomes and quality of life for patients. With a strong market position, LivaNova continues to achieve notable milestones, reinforcing its reputation as a trusted name in the healthcare industry.
How does LivaNova PLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
LivaNova PLC's score of 22 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, LivaNova PLC reported total carbon emissions of approximately 459,340 kg CO2e, with emissions distributed across various scopes: 71,950 kg CO2e from Scope 1, 4,220 kg CO2e from Scope 2, and a significant 383,170 kg CO2e from Scope 3. The Scope 3 emissions were primarily driven by business travel (205,100 kg CO2e) and upstream transportation and distribution (133,980 kg CO2e). The company has not disclosed specific reduction targets or initiatives as part of its climate commitments, and there are no emissions data cascaded from a parent organization. LivaNova's emissions data is self-reported, and it has not established any Science-Based Targets Initiative (SBTi) reduction targets or other formal climate pledges. Overall, LivaNova PLC's emissions profile highlights the importance of addressing Scope 3 emissions, which constitute the majority of its carbon footprint, while the absence of formal reduction commitments suggests an opportunity for the company to enhance its climate strategy moving forward.
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 7,269,000 | 0,000,000 | 000,000,000 | 00,000,000 | 
| Scope 2 | 24,598,000 | 00,000,000 | - | 0,000,000 | 
| Scope 3 | 59,761,000 | 00,000,000 | - | 0,000,000 | 
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
LivaNova PLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
